z-logo
Premium
Long‐term Efficacy and Toxicity of High‐ and Low‐Dose Amiodarone Regimens
Author(s) -
Kerin Nicholas Z.,
Aragon Eric,
Faitel Kathy,
Frumin Howard,
Rubernfire Melvyn
Publication year - 1989
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/j.1552-4604.1989.tb03354.x
Subject(s) - medicine , toxicity , amiodarone , term (time) , pharmacology , oncology , atrial fibrillation , physics , quantum mechanics
Amiodarone is an effective antiarrhythmic drug for the control of potentially lethal and lethal ventricular arrhythmias (VA). In the United States, a high‐dose regimen has been used at the expense of a high toxicity profile for the control of lethal VAs. Significant antiarrhythmic efficacy has also been established with low‐dose regimens, which carry a low rate of intolerable side effects (5.4%) when compared with the high‐dose regimen (16.7%). The high incidence of tolerable and intolerable adverse side effects is probably related to high amiodarone loading (31.92 g) and maintenance doses (520 mg/d). In contrast, the low‐dose regimen uses much lower loading (7.2 g) and maintenance (280 mg/d) doses.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom